Medicine for treating gastroesophageal reflux disease and application of medicine

Abstract

The invention provides a medicine for treating gastroesophageal reflux disease. The medicine is characterized by being prepared from the following medicine materials by weight: 6-12 parts of folium eriobotryae, 0.5-2 parts of platycodon grandiflorum and 6-12 parts of largehead atractylodes rhizome. The invention also provides the application of the medicine in drugs for treating gastroesophageal reflux disease, reflux esophagitis and non-erosive gastroesophageal reflux disease. The medicine for treating gastroesophageal reflux disease has the advantages that the clinical symptoms can be remarkably relieved when the medicine is used for treating the gastroesophageal reflux disease, symptoms of heartburn, acid regurgitation, anabole, causalgia post sternum, pharyngeal discomfort, belching, epigastric distention, epigastric pain are significantly improved, and the general curative effect of the medicine is similar to that of common clinically used acid-suppressive drug omeprazole and is similar to that of traditional Chinese medicine compositions disclosed in comparison files, but the medicine provided by the invention has advantages in improving individual symptoms; the medicine provided by the invention prepared from pure traditional Chinese medicine materials, has no toxic and side effects, and can be easily accepted by patients; the material components are less, the materials are abundant and low in price and are easily obtained, and the preparation process is simple and is suitable for being widely generalized and used.

Description

technical field [0001] The invention relates to a medicine for treating gastroesophageal reflux disease and its application, in particular, it is a Chinese patent medicine prepared from Chinese herbal medicine. Background technique [0002] Gastroesophageal reflux disease (GERD) is a disease in which the reflux of gastric contents causes discomfort symptoms and / or complications. Heartburn and reflux (reflux, pantothenic acid) are the characteristic symptoms of this disease , the main pathogenesis is the transient relaxation of the lower esophageal sphincter, which leads to the reflux of gastric contents into the esophagus. Among them, those with histopathological changes in the esophageal mucosa are called reflux esophagitis (RE), and those with GERD symptoms without endoscopic mucosal damage are called non-erosive gastroesophageal reflux disease (NERD). A nationwide survey in the United States showed that the prevalence of GERD was 14%, and the incidence increased with age...

AI Technical Summary

Problems solved by technology

However, the above-mentioned prior art used to treat gastroesophageal reflux disease consists of 4-6 medicines, which has the disadvantage of a large number of medicines, and the different pathological factors of GERD need to increase or decrease the medicines on the basic prescription to achieve a better result. Good curative effect, increasing the difficulty of diagnosis and treatment

Therefore, there is an urgent need for a drug for the treatment of GERD that does not require syndrome differentiation and treatment, has significant curative effect, and has fewer medicinal flavors, but there are no reports about this type of drug at present.

Images